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When BHK-21 cells with Semliki Forest virus (SFV) bound at the plasma membrane
are briefly treated with low pH medium (pH 5-6), fusion between the viral membrane and the
plasma membrane occurs, releasing the viral nucleocapsid into the cytoplasm. The fusion
reaction resembles that described previously for Sendai virus but with one fundamental
difference; it is strictly dependent on low pH . The fusion reaction is highly efficient. Up to 86%
of bound viruses fuse, and 6 X 106 virus spike proteins can be inserted into the plasma
membrane of each cell . The process is very rapid (full activity is observed after 5 s) and it
occurs over a wide temperature range and equally well with all five cell lines tested (BHK-21,
HeLa B, HeLa suspension, Raji, and 3T3) .
Low pH-induced fusion of the virus at the plasma membrane can lead to infection of
susceptible cells. The artificial nature of this infection pathway is, however, demonstrated by
the facts that infection through the plasma membrane occurs only at subphysiological pH and
that it is insensitive to inhibitors of the normal entry route. Nevertheless, these results indicate
that low pH membrane fusion introduces the viral genome into the cytoplasm in a form
suitable for replication .
Semliki Forest virus (SFV), an alphavirus, enters cells by
adsorptive endocytosis and is subsequently delivered to intra-
cellular vacuoles and lysosomes (1, 2). Our previous results
indicate that the final and critical step in the penetration ofthe
viral genome into the cytoplasm is a low pH-induced mem-
branefusion event between the viraland lysosomal membranes
(1-3). That SFV possesses membrane fusion activity, similar to
that observed for paramyxoviruses (4, 5), has recently been
confirmed by studies with erythrocytes (6, 7) and liposomes (1,
8). SFV causes hemolysis and erythrocyte fusion (6, 7), and it
fuses with artificial lipid bilayers (liposomes), introducing the
viral nucleocapsid into the internal space of the liposomes (8).
The fusion is very rapid, up to 96% efficient, and nonleaky (i.e.,
the internal contents of the virus and liposomes do not mix
with the external phase) (8). Cholesterol is required in the
target membranes, and the virus spike glycoproteins must be
intact. In contrast to the membrane fusion activity of para-
myxoviruses, the fusion events observed with SFV are strictly
dependent on a pH of 6 or below (6-8).
Here we show that low pH can trigger efficient fusion
between the SFV membrane and the plasma membranes of a
variety of tissue culture cells. The fusion inserts viral spike
264
glycoproteins into the plasma membrane and the nucleocapsid
into the cytoplasm. In some ofthe cell lines, the fusion results
in infection. However, because this method of infection has
features clearly different from those observed during normal
infection, fusion at the plasma membrane can be ruled out as
the physiological mechanism of SFV entry into host cells.
MATERIALS AND METHODS
Virus and Cells
A prototype strain of SFV was grown in BHK-21 cells and purified as
described (9). SFV was labeled with either ['SImethionine (Radiochemical
Centre, Amersham, England) (0.4 mCi/ml culture medium) or [3Hluridine (0.1
mCi/ml culture medium) (Radiochemical Centre), and stored as described
previously (1, 10). The specific activities were 3 x 103 virus particles per cpm'S
and 8.1 x 10` particles per cpm'H. BHK-21 cells were grown in Glasgow MEM
medium as described (1). HeLa B and 3T3 cells were grown in Eagle's MEM
with Earle's salts, 1096 fetal calf serum, 2 mM glutamine, 100 U/ml penicillin,
and 0.1 mg/ml streptomycin sulfate. The cells were grown in a 37°C, 5% COz
incubator (Forma Scientific, Inc., Mallinckrodt, Inc., Marietta, Ohio) and pas-
saged twice weekly. HeLa suspension cells were grown in Eagle's S-MEM
containing 1 g ofsodium bicarbonate/liter, 596 fetal calfserum, 5% newborncalf
serum, 100 U/mtpenicillin, and 0.1 mg/mlstreptomycinsulfate in Spinner flasks
at 37°C without C02 and split twice weekly at a ratio of 1:3 or 1 :4. Raji cells
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medium containing 10% newborn calf serum, fungizone (0.5 leg/ml), and kana-
mycin (100 Pg/ml) in falcon flasks (Falcon Labware, Div. of Becton, Dickson &
Co., Oxnard, Calif) in a 5% C02 incubator at 37°C. All ofthe reagents for tissue
culture were obtained from the Grand Island Biological Co., (Grand Island, N.
Y.). Plastic cell culture bottles (75 cm2, Falcon Labware) petri dishes (3.5 x 1.0
cm, Falcon Labware), 24-well Linbro trays (Linbro Div., Flow Laboratories,
Hamden, Conn.), and glass coverslips (I.I cm diameter) were used.
Fusion of SFV with the Cell Plasma Membrane
SFV in RPMI 1640 medium containing 0.2% bovine serum albumin (BSA,
fraction V, Armour Pharmaceutical, Co., Chicago, Ill.) and 10 mM HEPES
(Serva, W. Germany), pH 6.8 (binding medium) was allowed to bind to the cells
for 1.5 h at 4°C. The binding medium was removed and the cells were incubated
for the indicated time at 37°C in 1 ml of RPMI 1640 medium containing 0.2%
BSA, and 10 mM (2-[morpholino]ethane sulfonic acid, (MES, Serva) at varying
pH values. The medium was removed and replaced with RPMI medium at pH
7.2 and 4°C. Controls included cells that had not been treated with virus and
cells treated with virus but maintained at pH 7.2 throughout.
Proteinase K Treatment to Remove Bound SFV
Surface-bound SFV was removed from the monolayer cells (BHK-21, 3T3,
and HeLa B) using proteinase Kas described previously (1, 3). The amount of
virus bound was determined as described in reference 3. A slightly modified
procedure was employed to remove surface-bound [~S]methionine or [3H]uri-
dine-labeled SFV from suspension cells. The cells (2 x 106 in 1.5 ml Eppendorf
tubes (Hamburg, W. Germany]) were washed twice with binding medium, and
radioactively labeled SFV (50 td in binding medium) was allowed to bind to the
cells for I h on ice with occasional vortexing. The cells were pelleted, washed
once with binding medium, and then I ml of 37°C, pH 5.5 medium (RPMI, 10
mM MES, 0.2% BSA) was added. The cells were quickly resuspended by
vortexing, placed in a 37°Cwater bath for 30 s, and then chilled. After pelleting
(5,500 rpm, 4°C, in a table-topcentrifuge [Wifug, Stockholm, Sweden]), the cells
were resuspended and incubated for 45 min at 4°C in 0.5 ml of a phosphate-
buffered saline (PBS) solution containing 0.5 mg of proteinase K (Boehringer,
Mannheim, W. Germany) per ml. Then 0.5 ml ofPBScontaining 30 mg ofBSA/
ml (PBS-BSA) and 4mM phenylmethylsulfonyl fluoride (PMSF, Sigma Chem-
ical Co., St. Louis, Mo.) was added. Thecells were pelleted as above, and washed
two times with t ml of PBS-BSA, and transferred to scintillation vials with 3 ml
Triton X-100/toluol scintillation fluid (Rotiszint 22 (containing 800 ml H20/ 10
liter), Roth Chemical Co., Karlsruhe, W. Germany). An additional 6 ml of
scintillation fluid was added to each vial, and the radioactivity was determined
in a Mark III scintillation counter (Searle Analytic Inc., Des Plaines, Ill,). To
determine the amount of SFV bound, the cells (after the 1-h binding period in
the cold) were washed twice with cold binding medium and analyzed for cell-
associated radioactivity as above.
Electron Microscopy
For thin-section electron microscopy, confluent BHK-21 cells on coverslips
were incubated for l h with 8 ILg SFV in 50 Al binding medium on ice. The
coverslips were dipped rapidly into 37°C RPMI medium of the indicated pH
value for 2 or 10 s, then into ice-cold RPMI medium, pH 7.2, and then
immediately fixed for 30 min with ice-cold 2.5% glutaraldehyde in 0.05 M
cacodylate buffer, pH 7.2. Staining with ferritin-labeled antibodies to visualize
the viral glycoprotein spikes was conducted as follows: After the indicated
treatments, the cells were fixed for 20 min at room temperature with 0.75%
glutaraldehyde in 0.05 M cacodylate buffer, pH 7.2, treated with 2% BSAin PBS
for 40 minat room temperature, washed two times with PBS, and labeled for 30
min with 50 pl of rabbit anti-SFV antiserum diluted 1:4 in PBS. Thecells were
then washed twice with PBS, labeled for 30 min at room temperature with 50 kl
of ferritin-conjugated goat anti-rabbit IgG (Miles Laboratories Inc,, Miles Re-
search Products, Elkart, Ind.), diluted 1:10 in PBS, washed thoroughly in PBS,
and then fixed for 30 min in 2.5% glutaraldehyde in 0.05 M cacodylate buffer,
pH 7.2 on ice. All antibody solutions were centrifuged at 5,500 rpm to remove
aggregated material beforeuse. Dehydration,embedding, sectioning, and staining
with uranyl acetate were performed asdescribed previously (l, 11). A Philips400
electron microscope was employed.
( 3 H]Uridine Incorporation Assay
The incorporation of['H]uridine into viral RNA under different conditions of
infection was determined by a modification of the method of Miller et al. (12),
for which a detailed description will be presented elsewhere.' Briefly, BHK-21
cells were grown as confluent monolayers on I 1-mm diameter glass coverslips in
24-well Linbro trays. After washing with cold binding medium, 2 x 10' plaque-
forming units (PFU) o£ SFV(20 PFU/cell) were added to each well in 0.25 ml
cold binding medium. The virus was allowed to bind to the cells at 4°C for 10
min and, after the indicated treatments, the medium was replaced with 37°C
medium adjusted to pH 7.2. After 1.5 h at 37°C in a 5% C02 incubator,
actinomycin D was added to a final concentration of2 lig/ml to inhibit cellular
RNA synthesis, and after an additional 30 minat 37°C, ['H]uridine (2.5 ILCi in
0.25 ml medium containing 2 Wg/ml actinomycin D) was added to each well, and
thecells incubated for a further 2.5 h. The coverslips were then removed, washed
thoroughly with cold PBS containing 10 mM uridine, transferred to new trays
containing 1 ml of PBS/well for 15 minon ice, and then treated for 60 min with
10%TCAat 4°C. Thecoverslips were then removed, placed in scintillation vials,
and the radioactivity was determined after addition of 7 ml of Rotiszint 22.
Samples werepreparedin triplicate. Thebackground radioactivityinthe presence
of actinomycin D but in the absence of virus was <5% of the maximum
incorporation and was subtracted from the other values.
Other Methods
SDS polyacrylamide gel electrophoresis was conducted using a modified
Laemmli system (13). Samples of cellular material were prepared for analysis as
follows: Pelleted cells from one 35-mm petri dish were resuspended in 200 /Al of
buffer containing 2% SDS, 50 mM Tris, pH 8.0, 2 mM PMSF. The solution was
then passed up and down 20 times in a syringe fitted with a 22-gauge needle,
heated to 95°C for 5 min, and then 5-10-kl samples were reduced and alkylated
asdescribed in reference 13. Fluorography wasconducted as described previously
(8). Indirect immunofluorescence was conducted as described (1) using rabbit
anti-SFV-spike protein serum (14) and affinity-purified goat anti-rabbit IgG
labeled with 3 mol rhodamine/mol IgG. Antibody solutions were centrifuged to
remove aggregated material before use.
RESULTS
Effect of Lysosomotropic Weak Bases on
SFV Infection
Chloroquine, a lysosomotropic weak base, inhibits SFV
infection by preventing the penetration of the viral genome
into the cytoplasm (l, 3, and footnote 1). We observed previ-
ously that this inhibition could be bypassed if BHK-21 cells
with adsorbed virus were briefly treated with pH 5.5 medium
at 37°C (1). We have confirmed and extended this finding
using three lysosomotropic weak bases (chloroquine, ammo-
nium chloride, and methylamine) and a convenient [3Hiuridine
incorporation assay to determine the extent of infection. Vi-
ruses were allowed to bind to cells in the cold in neutral pH
medium which was replaced after 10 min with 37°C medium
at different specified pH values for 90 s. The cells were returned
to neutral medium and placed in a 37°C C02 incubator.
Infection was assayed after 4.5 h by determining the amount
of [3H]uridine incorporated into viral RNA. The indicated
lysosomotropic inhibitors were present in all of the solutions.
The results in Fig. 1 show that, at neutrality, SFV infection
was inhibited by 80-95% by the lysosomotropic weak bases. In
each case, however, the inhibition could be by-passed at pH 6
or below. The extent of infection at pH 5.5 in the presence of
chloroquine was reproducibly higher than in the control (Fig.
1) . Considering the similarity in the pH dependence of infection
(Fig. 1) and the virus fusion activity (6-8), the most likely
explanation for the bypass of inhibition was that the low pH
triggered fusion between the viral membrane and the plasma
membrane and thereby released the nucleocapsid directly into
the cytoplasm for replication.
' Helenius, A., M. Marsh, and J . White. Manuscript in preparation.
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Thin-section electron microscopy was used to determine
whether fusion occurred at the plasma membrane. When cells
with virus bound at the surface were warmed up at neutrality,
no fusion was observed; instead, viruses were seen entering the
cell in coated pits and coated vesicles as described previously
(1). Ifthe warming was performed at pH 5.5 as described above
for the inhibitor experiments and the cells fixed after 2-10 s,
fusion was observed (Fig. 2). It occurred mainly at the micro-
villi which are the preferential binding sites for SFV on BHK-
21 cells (1) and was also often seen at the edges of coated pits
but never within the coated regions (Fig. 3).
Several stages of fusion could be seen in samples fixed after
10 s of warning. Apparently the fusion begins by a close
approach of the viral membrane and the plasma membrane.
The distance between the two membranes (9-12 nm at neu-
trality, Fig. 2 a) is reduced to 5 nm or less (Fig. 2 b). A narrow
neck region is formed between the membranes (Fig. 2 c) which
widens (Fig. 2 df), revealing the continuity between the mem-
branes (Fig. 2 h and k). The densely stained spherical nucleo-
capsid (diameter 33 nm) becomes clearly visible underlying the
membrane (Fig. 2 k) and, in the next stage, it dissociates from
the membrane (Fig. 2 i-k). After a 5-min further incubation at
pH 7.2, intracellular nucleocapsids were only occasionally ob-
served, and after20 min they could no longer be seen. However,
the viral spike proteins could still be identified in the plasma
membrane by indirect immunoferritin staining. Initially, the
spike proteins are restricted to the fusion site (Fig. 4) but, at
later times, when the nucleocapsids are no longer discernible,
the spike proteins appear diffusely distributed along the plasma
membrane surface. The fusion process, although reversed in
direction, is morphologically quite similar to the budding of
virus particles from infected cells. The nucleocapsid size (33
nm) and shape are the same and similar intermediate stages
seem to be involved. Whereas fusion occurs mainly on the
microvilli, the budding does not display such preference (15).
Quantitative Assay for Fusion
To determine the fusion quantitatively, we took advantage
of the fact that the cell surface receptors for SFV on BHK-21
cells are sensitive to proteinase K digestion in the cold. The
enzyme removes 97% of viruses bound to the cell surface with
little damage to the virus itself or to cell viability (1, 3).
Morphological and biochemical methods were employed to
show that proteinase K could be utilized to differentiate be-
tween bound and fused viruses.
SFV was allowed to bind to confluent cell monolayers at
4°C, at which temperature no endocytosis occurs (3). The cells
were then incubated for 30 s at 37°C in medium of pH 7.2 or
5.5, chilled to 4°C, and digested with proteinase K in the cold.
Indirect immunofluorescence using rabbit anti-SFV-spike pro-
tein antiserum and rhodamine-labeled goat anti-rabbit IgG
was used to detect viral spike protein antigens that remained
on the cell surface. The results in Fig. 5 show that the cells
kept at pH 7.2 throughout(Fig. 5 c and d) lost all viral surface
proteins during the proteinase K treatment, whereas the cells
subjected to low pH treatment were brightly stained (Fig. 5 b).
The stain occurred in patches, and in many cases only one
segment of the cell surface (presumably the part originally
facing the bulk solution) was stained (Fig. 5a and b). Thin-
section electron microscopy confirmed that neither cell prepa-
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FIGURE 1 pH dependence of SFV infection in the presence of
lysosomotropic weak bases. Virus (20 PFU/cell) was allowed to bind
to BHK-21 cells in Linbro trays for 10 min on ice. The cells were
then warmed by addition of 2 ml of serum-free MEM (37°C)
containing 0.2% BSA and 10 mM MES adjusted to the indicated pH .
After 90 s, the media were removed, and replaced with 1 ml of pH
7.2 serum-free medium containing 0.2% BSA and 10 mM HEPES and
the cells were incubated in a 37°C, C02 incubator for 1 .5 h . The
incorporation of [3H]uridine during a 3-h labeling period in the
presence of actinomycin D was then determined. All solutions
except the uninhibited controls contained lysosomotropic agents:
(0) 0.2 mM chloroquine, (O) 20 mM NHaCl, and (") 20 mM
methylamine.
ration contained virus particles on the cell surface.
These results were confirmed biochemically with [35S]methi-
onine-labeled SFV. After virus binding in the cold, cells were
warmed up at pH 7.2 or pH 5.5 for 30 s and chilled to 4°C.
One plate of cells treated at pH 7.2 and another treated at pH
5.5 were digested with proteinase K in the cold, washed, and
solubilized in SDS. Fig. 6 shows a fluorogram obtained after
SDS gel electrophoresis. It is clear (see lanes 1 and 2) that
proteinase K removes virtually all of the virus proteins origi-
nally bound to the cells which were kept at neutral pH. The
barely visible traces of E1/E2 (the membrane glycoproteins)
and the capsid (C) protein (the only protein component of the
nucleocapsid) seen in lanes 2 and 4 probably represent the
small amount of endocytosed viruses. During a 30-s warming
period, only 5% of the surface-bound SFV is endocytosed (3,
see Fig. 9, below). In agreement with the immunofluorescence
results, the cells warmed at pH 5.5 retained most of the viral
proteins in a proteinase K resistant form (lane 3). Proteinase K
could also be used to show that after low pH treatment the
spike glycopolypeptides E l and E2 were at the plasma mem-
brane of the cell. We have previously observed that the viral
surface proteins are sensitive to proteinase K if digestion is
performed at 37°C instead of on ice (8). Lane 5 shows that
when the cells that had been incubated at pH 5.5 were digested
at 37°C, the spike proteins were digested but the C protein was
not. This provides biochemical evidence that the nucleocapsid
has been internalized and that the spike glycoproteins remain
at the plasma membrane accessible to the bulk solution.
These results show that proteinase K digestion in the cold
can be used to quantitate the amount of radioactively labeled
virus that has fused at the cell surface.FIGURE 2
￿
Interaction of SFV with the plasma membrane at pH 5 .5 . Viruses were allowed to bind to cells in the cold, whereafter
the cells were either fixed directly (a), or after warming to 37°C in pH 5 .5 medium for 2 s (a-g) or 10 s (h-k) . Fusion occurs
preferentially at the microvilli . The initial stage in the fusion is the close approach of the viral and plasma membranes (b) . The next
stage is characterized by the formation of a neck region between the two membranes (arrow in c) which widens (e .g ., d-f),
revealing the continuity between the viral and plasma membranes (e .g ., upper right in h, inset in j) . At later time points, the
nucleocapsids can be seen either underlying the plasma membrane (h, j, and k) or freely dissociated in the cytoplasm (i and k) .
Bars, 0.1 pm ; (a) x 150,000; (b) x 135,000; (c-h and k) x 93,000 ; (i) x 80,000 ; (j) x 110,000 ; insetx 185,000 .




Fusion of SFV does not occur in coated pits . Fusion is, however, seen at the edges of the coated region . Virus was
allowed to bind to cells in the cold, after which the cells were warmed to 37°C in pH 5 .5 medium for 10 s before fixation . Bars, 0.1
ILm . x 115,000 .
FIGURE 4
￿
Visualization of SFV spike proteins on the BHK-21 cell surface as detected by indirect immune electron microscopy
using ferritin-labeled antibody . Virus was allowed to bind to cells in the cold . The cells were then warmed to 37°C for 30 s in pH
5 .5 medium and then further incubated in pH 7.2 medium for 5 min . The spike proteins are initially seen localized at the fusion site
(arrows) . Bar, 0.2 jAm . x 165,000 .
Properties of the Fusion Reaction
Using resistance to proteinase K as an assay, we character-
ized the efficiency of fusion between SFV and the plasma
membrane ofBHK-21 cells under different conditions . When
trace amounts of "S-methionine-labeled virus were used,
we found that 84% of the cell-bound viruses fused with the
plasma membrane during a 30 s warming period with pH 5.5
medium . As the amount of virus was increased, the relative
efficiency of fusion decreased (Table I). At the highest virus
concentration, 2 .5 x 10" viruses were fused per cell. Because
there are 240 spike proteins (16) and 3.5 x 10' lipid molecules
(17) per virus, this amounts to the incorporation of 6 x 106
spike proteins and 8.7 x 10 8 lipid molecules into the plasma
membrane. Using 8.4 x 10-3 'Um2 as the membrane area of a
virus particle (18) and 5 x 103 tm2 as the surface area of a
BHK-21 cell (1), this insertion increases the plasmamembrane
surface area by 4% .
Fig . 7 shows that fusion at the plasma membrane is strictly
dependent on low pH . The pH dependence curve is identical
268
￿
THE JOURNAL OF CELL BIOLOGY " VOLUME 87, 1980
to that previously observed for fusion between SFV and lipo-
somes (8), but slightly shifted compared to thepH dependence
ofinfection seen in the presence of lysosomotropic agents (Fig.
1) .
Although maximal between 25' and 35'C, fusion was ob-
served over a wide temperature range (Fig . 8). Considerable
fusion (25% of maximal) was observed at 0°C, in agreement
with our results using liposomes as target membranes (8) .
When cells with prebound virus were treated at 37°C with pH
5.5 medium, the virus became proteinase K resistant extremely
rapidly with full effect at 5 s (Fig. 9) . In controls where the pH
was kept at 7 .2, there was a slow increase in protection, owing
to the adsorptive endocytosis of viruses (3).
To determine whether lysosomotropic weak bases affect the
fusion reaction, chloroquine (0.2 mM), amantadine (0.5 mM),
andammonium chloride (20mM) were included in the binding
and the fusion media . Fusion was induced by a 30-s drop in
pH to 5 .5 at 37°C, and the extent of fusion was determined
using proteinase K in the cold . The lysosomotropic agents had
no significant effect on fusion.FIGURE 5
￿
Distribution of SFV spike glycoproteins on the surface of proteinase K treated BHK-21 cells . Virus was allowed to bind
to cells at 4°C . The cells were warmed to 37°C with pH 5.5 (a and b) or pH 7 .2 (c and d) media for 30 s, treated with proteinase
K for 45 min in the cold, and stained for spike proteins by indirect immunofluorescence. Often, only one part of the cells treated
at low pH (probably the part originally facing the medium) was fluorescent . Nomarsky optics (a and c) . Fluorescence optics (b and
d) . Bars, 30 P.m . x 1,000.
FIGURE 6
￿
Proteinase K sensitivity of SFV proteins after binding and
fusion with the BHK-21 plasma membrane. [35S]Methionine-labeled
SFV was bound to cells in the cold . The cells were warmed to 37°C
in pH 7 .2 (lanes 2 and 4) or pH 5.5 (lanes 3 and 5) media for 30 s,
incubated with proteinase K for 45 min on ice (lanes 2 and 3) or at
37°C (lanes 4 and 5), and prepared for SDS gel electrophoresis .
Untreated SFV (lanes 1 and 6) .
Fusion and Infection with Various Cell Lines
We determined the extent ofSFV fusion with confluent 3T3
cell monolayers and with Raji and HeLa cells in suspension .
TABLE I
Efficiency of Fusion between SFV and the BHK-21 Cell Plasma
Membrane
["S]Methionine-labeled SFV was allowed to bind to BHK-21 cells for 1 h in
the cold in RPM] medium containing 0.2% BSA and 10 mM HEPES, pH 6.8.
The number of viruses bound was determined directly and the number of
viruses fused by the proteinase K assay after a 30-s warming period at pH 5.5,
37°C .
The cells varied in their virus binding capacity, but with all of
them, the relative fusion efficiency, as determined by proteinase
K resistance, was equally high (?70%) (Table II) . These results
were confirmed by indirect immunofluorescence after protein-
ase K treatment by the method described in Fig. 5 .
To determine whether the cells were infected by the fusion,
a test similar to that described in Fig . 1 was repeated for the
3T3, HeLa B, BHK-21, Raji, and HeLa suspension cells. In
this case, virus (10 PFU/cell) was allowed to bind to the cells
for 1 h in the cold and, after a brief (90 s) treatment at 37'C
with pH 7.2 or pH 5.5 medium (with or without chloroquine
as indicated), the cells were returned to neutral pH and further








(x 10-° ) % Fusion
0.043 0.036 84
4.2 3 .5 83
5 .7 2 .7 47
5 .8 2 .6 45FIGURE 7 pH dependence of SFV fusion with the plasma mem-
brane of BHK-21 cells. [3H]Uridine-labeled SFV was bound to BHK-
21 cells for 1 h in the cold in RPMI 1640 medium containing 0.2%
BSA and 10 mM HEPES, pH 6.8. The cells were warmed to 37*C for
30 s by adding 1 ml of 37°C RPMI 1640 medium (containing 0.2%
BSA and 10 mM MES) at the indicated pH values. These media were
then removed, the cells were chilled, subjected to proteinase K
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FIGURE 8 Temperature dependence of fusion between SFV and
the plasma membrane. [3H]Uridine-labeled SFV was bound to cells
in the cold as described in the legend to Fig. 7. The cells were then
incubated in a thermostated water bath for 30 s in 1 ml of pH 5.5
medium at the indicated temperature, after which they were chilled
to 2'C, treated with proteinase K, and assayed for proteinase K
resistant [3H]RNA.
incubated for 9 h in a 37°C, 5% COz incubator. At this time,
the amount of virus in the culture medium was determined
using the [3H]uridine incorporation assay. In the absence of
chloroquine, the 3T3, HeLa-B and BHK-21 cells were infected,
whereas the Raji and HeLa suspension cells were not. None of
the cell lines was infected in the presence of chloroquine at
neutral pH (Table III). The chloroquine block could, however,
be circumvented by a brief(90 s) low pH treatment of the 3T3,
HeLa-B, and BHK-21 cells, suggesting that fusion of SFV at
the plasma membrane of these cells introduced the viral ge-
nome into the cytoplasm in a replicable form and resulted in
the production ofvirus particles. However, the Raji and HeLa
suspension cells could not be infected by this procedure. For
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these cells, it is apparently not sufficient to introduce the viral
nucleocapsid directly into the cytoplasm. Their resistance to
SFV infection cannot therefore be attributed to a block in the
entry pathway of the viral genome.
DISCUSSION
Two pathways are generally considered in the entry of enve-
loped animal viruses into cells (19, 20). In the first, viruses may
fuse with the plasma membrane and thereby insert their ge-
nomes directly into the cytoplasm. Such fusion is best docu-
mented for Sendai and other paramyxoviruses (4, 5, 21). These
viruses possess a specific membrane glycoprotein, the fusion
protein, which mediates the process (22-24). The second route,
which appears to be employed by most other enveloped viruses,
is endocytosis of the particle into the cell, afterwhich the viral
genome is liberated into the cytoplasm by unknown mecha-
nisms (19, 20).
Under normal tissue culture conditions, SFV enters cells by
endocytosis (1-3). After binding to the cell surface, the virus
particles are internalized by adsorptive endocytosis in coated
vesicles and routed into intracellular vacuoles and lysosomes.
How the genome finally enters the cytoplasm is not known in
detail, but our previous studies strongly suggest that fusion
between the viral membrane and the membrane of the lyso-







Time dependence of fusion between SFV and the plasma
membrane. [3H] Uridine-labeled SFV was bound to cells in the cold
as described in the legend to Fig. 7. The cells were then warmed to
37°C by submersion in pH 5.5 (") or pH 7.2 (O) RPMI 1640 medium .
After the indicated times, the media were removed and the cells
were immediately chilled, treated with proteinase K, and analyzed
for proteinase K resistant ['H] RNA.
Fusion of SFV with Various Cells




pH 7.2 pH 5.5
% Fu-
sion
cpm x 10-3 cpm x 10-3
3T3 47.0 2.6 41.0 87
Raji 6.6 1 .1 4.6 70
Hela suspen- 37.0 4.0 27.0 73
sion
BHK-21 5.8 0.3 5.0 86TABLE III
SFV Infection by Fusion with the Plasma Membrane
* SFV (10 PFU/cell) was allowed to bind to the various cells for 1 h on ice in
serum-free MEM containing 0.2% BSA and 10 mM HEPES, pH 6.8. The cells
were then warmed for 90 s to 37°C in pH 7.2 or pH 5.5 media and then
incubated in MEM containing 10% fetal calf serum in a 37°C, 5% COZ
incubator for 2 h. The medium was then replaced with 1 .2 ml serum-free
MEM containing0.2% BSA and 10 mM HEPES, pH 7.2, and after an additional
7 h in the 37*C C02 incubator, the cell medium was centrifuged to remove
cellular debris and then 0.25-ml samples were assayed for virus by the
[3H]uridine incorporation assay. A standard curve was prepared using virus
samples of known titer (determined by plaque titration). In the chloroquine
(+) samples, 0.2 mM chloroquine was present in all but the final incubation
media.
thereby transferring the nucleocapsid into the cytoplasm. The
fusion is probably triggered by the low lysosomal pH, because
agents that raise the pH in the lysosomes inhibit release of the
viral genome into the cytoplasm (1-3, and footnote 1).
The results described in this paper show that SFV can also
infect susceptible cells afterfusion with the plasma membrane.
As in the liposome system, which we have studied in some
detail (8), fusion requires low pH. Because the pH must be 6 or
lower, fusion at the plasma membrane is unlikely, as the entry
mechanism under normal tissue culture conditions. The artifi-
cial nature of this pathway is also demonstrated by the fact
that it is completely insensitive to lysosomotropic agents which
are potent inhibitors of the normal route of SFV penetration
(1). Moreover, fusion of the virus with the plasma membrane
at neutral pH is never observed in the electron microscope,
and, unlike Sendai virus, viralspike proteins are not left in the
plasma membrane after normal infections (25, K. Simons,
unpublished results).
Despite the artificial nature of SFV penetration through the
plasma membrane, the results described in this paper are
relevant to our understanding of the normal route of entry of
SFV into host cells. First, they emphasize that fusion triggered
by low pH is an effective way of introducing the SFV nucleo-
capsid into the cytoplasm in an infectine form. This is compat-
ible with our suggestion that fusion induced by the low pH in
lysosomes may be the final step in SFV penetration under
physiological conditions (1, 2). Second, the lack of inhibition
of fusion and infection by weak bases after low pH treatment
shows that fusion, uncoating, and the rest of the viral replica-
tion cycle are not directly affected by these agents. This agrees
with our proposal that the inhibition by lysosomotropic agents
is caused by elevation of the intralysosomal pH above the
critical value required for fusion (1, 2). Third, the demonstra-
tion that low pH-induced fusion through the plasma membrane
leads to infection of susceptible cells supports the idea that
lysosomal modification of the virus is not required for fusion
(i.e., that the low pH in the lysosomes may be the only factor
needed to trigger fusion). Fourth, the results show that after
dropping the pH in the medium, fusion occurs very rapidly,
and that the nucleocapsid as a recognizable morphological unit
is short-lived in the cytoplasm. The rapidity of fusion may
explain why we have not been able to recognize fusion in the
lysosomes by electron microscopy. The reason why fusion is
readily visualized at the plasma membrane is that the process
can be synchronized by a drop in pH. The speed of fusion also
makes it easier to understand how the virus might escape
degradation in the lysosomes. Because the viral spike glycopro-
teins must be intact for fusion to occur (8), degradation by
lysosomal proteases would prevent fusion and hence the pen-
etration of the viralgenome into the cytoplasm.
Fusion could be demonstrated with all five cell lines tested.
The reaction thus appears to be nonselective. Apparently, the
cell's plasma membrane must only possess binding sites for the
virus and, by analogy to the liposome system (8), it must
contain cholesterol. In practice, neither of these requirements
is very limiting, as SFV binds to most tissue culture cells (26),
and because cholesterol is a major component of the plasma
membrane (27). The fusion reaction was maximally 86% effi-
cient and it provides a convenient mechanism for introducing
the viral membrane proteins and lipids into the plasma mem-
brane of a variety of cells. In this way, the plasma membrane
can be specifically labeled, facilitating studies of the turnover,
recycling, lateral diffusion, and polarity of the cell surface and
its components.
Another potential use for low pH-induced fusion is the
possibility ofartificially infecting cells. When the normal route
of entry into susceptible cells is blocked by lysosomotropic
agents, infection can be induced by fusion at the plasma
membrane. However, the two cell lines so far tested, which are
refractory to infection under normal conditions, could not be
infected by this procedure. The reason for this result is not
clear, and more cell lines will have to be tested to verify the
generality of the effect. It may be relevant that the Raji cells
are also refractory to infection by vesicular stomatitis virus,
another enveloped RNA virus, and that this resistance cannot
apparently be attributed to the production of interferon (28,
29). It will be interesting to elucidate the step at which infection
is blocked in the refractory cell lines. Using fusion through the
plasma membrane, it may also be possible to identify cells
which possess a block in the entry pathway.
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